Therefore, we conducted a retrospective study analysing the sera of a large cohort of DLBCL patients from the NHLB1/2 study, to evaluate the prevalence of ACPA together with RF-IgM, -IgG, and -IgA in comparison with healthy controls. The gene discussed is CD40LG; the disease is diffuse large B-cell lymphoma.